Convergence Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Convergence Financial's ABBV Position: Q2 2026 in Review
Convergence Financial increased its AbbVie (ABBV) stake by 92% in Q2 2026, buying an estimated $584K and bringing the position to 5,670 shares worth $1.43M. The position accounts for 0.11% of the portfolio, ranked #97.
Convergence Financial first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Convergence Financial held 5,670 shares of AbbVie worth $1.43M as of Q2 2026.
- Convergence Financial bought 2,713 AbbVie shares in Q2 2026, an estimated $584K.
- AbbVie made up 0.11% of Convergence Financial's portfolio in Q2 2026, its #97 holding.
- Convergence Financial first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Convergence Financial's 13F filing for Q2 2026, filed 5 Aug 2026.